How can we better prepare for future pandemics and health crises? This central question was the focus of the event “Biomedical Preparedness and Health Resilience,” hosted by the Pandemic Alliance Munich (PAM) in collaboration with BioM at the Bavarian Academy of Sciences. Over 100 participants from academia, industry, healthcare, and politics came together to discuss perspectives and innovative approaches to preparing for potential pandemic and crisis situations in healthcare. It became clear that effective preparation for infectious disease outbreaks can only be achieved through the interplay of prevention, surveillance, and rapid response capabilities. In this context, Bavaria plays a central role in the further development of innovative healthcare solutions thanks to its strong research landscape and targeted initiatives.
The event brought together leading national experts, including representatives from Roche, the Robert Koch Institute, the Bundeswehr, Fraunhofer, Helmholtz Munich, both Munich universities, and other key organizations in the fields of infectious disease research and healthcare innovation.
Following opening remarks by BioM Managing Director Prof. Ralf Huss, Bavaria’s Minister of Health and Prevention Judith Gerlach opened the event with a policy statement on the importance of proactive healthcare.
Gerlach emphasized the critical role of the healthcare sector during crises and explained: “We must set up the healthcare system so that it continues to function even in emergencies. This can only be achieved by working together. Bavaria is leading the way in this regard and is making targeted investments in innovative structures and partnerships. We have a close alliance and a strong network of expertise. Our goal is clear: We want to be as prepared as possible to protect people’s health even in future crises.”
The event showed that effective pandemic prevention can only succeed through an integrated combination of prevention, surveillance, and rapid response capabilities. Bavaria is contributing to this effort both through its strength as a leading research hub and through targeted initiatives.
Key messages for the future design of healthcare and resilience can be derived from the discussions:
Another key focus was on how cross-sectoral collaboration can be strengthened. In interactive discussion formats, participants exchanged views on the necessary framework conditions for innovation in healthcare – ranging from data infrastructure and regulatory aspects to financing and international cooperation.
Regina Bach, Project Coordinator for the Pandemic Alliance Munich at BioM, explained: “The discussions made it clear: innovative approaches, cooperation, and coordination are crucial for preparing for future pandemic events. With the Pandemic Alliance Munich, we are bringing these elements together to prepare specifically for future pandemic events.”
The event’s strong reception and intense discussion underscore the urgent need for action – and, at the same time, the strong willingness of all stakeholders to work together on solutions.
Pandemic Alliance Munich (PAM)
The Pandemic Alliance Munich (PAM) is a public-private initiative coordinated by BioM and funded by the Bavarian State Ministry of Economic Affairs, Regional Development, and Energy to prepare for future pandemics and infectious disease outbreaks. It connects stakeholders from research, clinical settings, SMEs, and industry to pool interdisciplinary expertise and drive innovation throughout the entire pandemic cycle – from prevention and early detection to diagnostics, treatment, and implementation. The goal is to strengthen the scientific, technological, and organizational foundations for a rapid and coordinated response to health threats through close collaboration.
More information: www.bio-m.org/pandemic-alliance-munich
The event brought together leading national experts, including representatives from Roche, the Robert Koch Institute, the Bundeswehr, Fraunhofer, Helmholtz Munich, both Munich universities, and other key organizations in the fields of infectious disease research and healthcare innovation.
Following opening remarks by BioM Managing Director Prof. Ralf Huss, Bavaria’s Minister of Health and Prevention Judith Gerlach opened the event with a policy statement on the importance of proactive healthcare.
Gerlach emphasized the critical role of the healthcare sector during crises and explained: “We must set up the healthcare system so that it continues to function even in emergencies. This can only be achieved by working together. Bavaria is leading the way in this regard and is making targeted investments in innovative structures and partnerships. We have a close alliance and a strong network of expertise. Our goal is clear: We want to be as prepared as possible to protect people’s health even in future crises.”
The event showed that effective pandemic prevention can only succeed through an integrated combination of prevention, surveillance, and rapid response capabilities. Bavaria is contributing to this effort both through its strength as a leading research hub and through targeted initiatives.
Key messages for the future design of healthcare and resilience can be derived from the discussions:
- Pandemics do not respect borders: international health protection is national health protection – nobody is safe until everyone is safe.
- We must adopt dual-use strategies to ensure that prevention, diagnostics, therapeutics, and surveillance are crisis-ready – pandemic preparedness is not optional, especially in times of geopolitical challenges.
- Research, development, and production need to be independent from third countries and global supply chains.
- Clear responsibilities and governance are crucial, alongside more speed, more money, and less bureaucracy.
- Environmental factors matter for public resilience. If ignored, it affects public health and increases healthcare costs.
- Building trust requires training of communicators, medical staff, and the broader population.
- We have to build bridges by aligning language, data, structures, and activities across borders.
Another key focus was on how cross-sectoral collaboration can be strengthened. In interactive discussion formats, participants exchanged views on the necessary framework conditions for innovation in healthcare – ranging from data infrastructure and regulatory aspects to financing and international cooperation.
Regina Bach, Project Coordinator for the Pandemic Alliance Munich at BioM, explained: “The discussions made it clear: innovative approaches, cooperation, and coordination are crucial for preparing for future pandemic events. With the Pandemic Alliance Munich, we are bringing these elements together to prepare specifically for future pandemic events.”
The event’s strong reception and intense discussion underscore the urgent need for action – and, at the same time, the strong willingness of all stakeholders to work together on solutions.
Pandemic Alliance Munich (PAM)
The Pandemic Alliance Munich (PAM) is a public-private initiative coordinated by BioM and funded by the Bavarian State Ministry of Economic Affairs, Regional Development, and Energy to prepare for future pandemics and infectious disease outbreaks. It connects stakeholders from research, clinical settings, SMEs, and industry to pool interdisciplinary expertise and drive innovation throughout the entire pandemic cycle – from prevention and early detection to diagnostics, treatment, and implementation. The goal is to strengthen the scientific, technological, and organizational foundations for a rapid and coordinated response to health threats through close collaboration.
More information: www.bio-m.org/pandemic-alliance-munich
